JENNIFER GREEN: Open Payments
NPI 1013030824 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 11 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $736 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, AVEIR, Auvelity, Rybelsus, VIVITROL, Ozempic, AIRSUPRA, Qelbree.
Industry payments across SC — which companies pay providers there.
